Nutex Health Receives Approval for Dual-Listing on Nasdaq Texas
Nutex Health (NUTX) has received approval to dual-list its common stock on the Nasdaq Texas exchange. The company plans to begin trading under this new listing at the market open, expected around September 23, 2026. This move is part of Nutex's strategy to enhance liquidity and expand access for investors by being listed on an additional major platform. Dual-listing can provide greater visibility and potentially attract a broader investor base, which may support long-term growth objectives.
Tickers: $NUTX
Topics: dual-listing Nasdaq Texas stock listing